BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • Michael Porter
    Michael Porter, M.D., MS
    University of Washington

    Michael P. Porter, M.D., MS is an Associate Professor of Urology and Adjunct Associate Professor of Epidemiology at the University of Washington and a member of the Seattle Cancer Care Alliance. He earned his MD at the University of Iowa and completed an internship in general surgery and residency in urology at the University of Washington. Dr. Porter earned a masters degree in epidemiology during his surgical residency and completed a 2 year health service research fellowship with the Robert Wood Johnson Clinical Scholars Program at the University of Washington before joining the faculty in 2005.

    Dr. Porter is the Assistant Chief of Urology at the VA Puget Sound health Care System where he has cares for Veterans with bladder, prostate and kidney cancer. He is an educator who serves at the Medical Student Clerkship Director for the Department of Urology and he works daily with urology residents at all levels of training. Dr. Porter is a member of the National Cancer Institute’s Bladder Cancer Task Force, and serves as a member on the National Comprehensive Cancer Network’s Bladder Cancer treatment guideline panel. He is a member of the Society of Urologic Oncology and the American Urological Society. He has authored over 40 peer reviewed scientific papers, and his research interests include advanced imaging modalities for bladder cancer surveillance, outcomes of surgical care for urologic cancer, and disparities in urologic surgical cancer care.

    To learn more about Dr. Porter and the Urologic Oncology team at the University of Washington, click here.